Emerging Therapeutic Strategies Transforming Myelofibrosis Care in 2026

Here are the two citations, formatted for clarity:

1. ClinicalTrials.gov. Study of Selpercatinib in Participants With Advanced Solid Tumors With RET Fusion-Positive. NCT06479135. Accessed January 20, 2026. https://www.clinicaltrials.gov/study/NCT06479135

2. Karyopharm. Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026.January 12, 2026. Accessed January 20,2026. https://investors.karyopharm.com/2026-01-12-Karyopharm-Announces-Preliminary-Unaudited-2025-Revenue-and-Reiterates-Expectation-of-Delivering-Potentially-Transformative-Phase-3-Data-in-2026

I’ve formatted them to be more standard citation style, including the association name, title, date (where available), and URL.